Reversing sarcopenia with megestrol acetate ameliorates systemic inflammation and improves survival in NSCLC
- DOI
- 10.1016/j.tranon.2026.102891
- Published
- 2026-11
- Container
- Translational Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.tranon.2026.102891,
title = {Reversing sarcopenia with megestrol acetate ameliorates systemic inflammation and improves survival in NSCLC},
author = {Yamin Zhang and Xubo Huang and Binghan Luo and Lili Jiang and Wenjuan Wang and Yichen Song and Xiaochi Li and Zehui Zhu and Jingya Huang and Hui Guo and Mengjie Liu},
year = {2026},
journal = {Translational Oncology},
doi = {10.1016/j.tranon.2026.102891},
url = {https://doi.org/10.1016/j.tranon.2026.102891}
}RIS
TY - JOUR TI - Reversing sarcopenia with megestrol acetate ameliorates systemic inflammation and improves survival in NSCLC AU - Yamin Zhang AU - Xubo Huang AU - Binghan Luo AU - Lili Jiang AU - Wenjuan Wang AU - Yichen Song AU - Xiaochi Li AU - Zehui Zhu AU - Jingya Huang AU - Hui Guo AU - Mengjie Liu PY - 2026 JO - Translational Oncology DO - 10.1016/j.tranon.2026.102891 UR - https://doi.org/10.1016/j.tranon.2026.102891 ER -
APA
Zhang, Y., Huang, X., Luo, B., Jiang, L., Wang, W., Song, Y., Li, X., Zhu, Z., Huang, J., Guo, H., & Liu, M. (2026). Reversing sarcopenia with megestrol acetate ameliorates systemic inflammation and improves survival in NSCLC. Translational Oncology. https://doi.org/10.1016/j.tranon.2026.102891
Source records
- crossref · retrieved 2026-09-27T17:43:38.815Z